Bioethics News

Blood Cancer Treatment Ages Immune Cells by 30 Years, Study Says

September 2, 2016

(UPI) – Stem cell transplants are a key treatment for blood cancers, but researchers found that for some patients it may age their immune cells by as much as 30 years. Researchers at the University of North Carolina found blood cancer patients treated with an autologous stem cell transplant showed elevated levels of expression of messenger RNA comparable to advanced aging, and at levels higher than with other stem cell transplant therapies, according to a study published in the journal EBioMedicine.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.